The comparative effectiveness of mail order pharmacy use vs. local pharmacy use on LDL-C control in new statin users

Journal of General Internal Medicine

Volumn 26, Issue 12, 2011, Pages 1396-1402

  Schmittdiel, Julie A ^a   Karter, Andrew J ^a   Dyer, Wendy ^a   Parker, Melissa ^a   Uratsu, Connie ^a   Chan, James ^b   Duru, O Kenrik ^c  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

health services research; hyperlipidemia; pharmaceutical care

Indexed keywords

EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; ETHNICITY; FEMALE; GENDER; HUMAN; LOCAL PHARMACY; MAIL ORDER PHARMACY; MAJOR CLINICAL STUDY; MALE; PHARMACY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; PHARMACIES; POSTAL SERVICE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 83655203456     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1805-7     Document Type: Article

References (36)

1. Pharmaceutical Strategies Group, 2011. http://www.psgconsults.com/ resources/pbm-101.pdf. Accessed June 24, 2011.
2. Federal Trade Commission. Pharmacy Benefit Managers: Ownership of Mail-Order Pharmacies. Washington, DC: Federal Trade Commission; 2005.
3. National Association of Chain Drug Stores, Industry "Facts at a Glance." http://www.nacds.org/wmspage.cfm?parm1=6536. Accessed June 24, 2011.
4. Fein AJ. The impact of Walmart's National Mail Pharmacy. Drug Channels, September 16, 2009. http://www.drugchannels.net/2009/09/impact-of-walmarts- national-mail.html. Accessed June 24, 2011.
5. M Johnsrud KA Lawsen MD Shepherd 2007 Comparison of mail order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans J Manage Care Pharm 13 2 122 134
6. NV Carroll I Brusilovsky B York R Oscar 2003 Comparison of costs of community and mail service pharmacy J Am Pharm Assoc 45 3 336 343 10.1331/1544345054003796
7. S Valluri E Seoane-Vazquez R Rodriguez-Monguio SL Szeinbach 2007 Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy BMC Health Serv Res 7 122 129 17663768 10.1186/1472-6963-7-122
8. BE Clark MV Siracuse RI Garis 2009 A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans Res Social Adm Pharm 5 2 133 142 19524861 10.1016/j.sapharm.2008.06.002
9. BR Motheral SM Heinle 2004 Predictors of satisfaction of health plan members with prescription drug benefits Am J Health Syst Pharm 61 10 1007 1014 15160776
10. JA Johnson SJ Coons RD Hays D Sabers P Jones PC Langley 1997 A comparison of satisfaction with mail versus traditional pharmacy services J Manag Care Pharm 3 327 337
11. Linton A, Garber M, Fagan NK, Peterson M. Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older. JMCP. 2007;13(8):677-86.
12. Liberman JN, Wang Y, Hutchins DS, Slezak J, Shrank WH. Revealed preference for community and mail service pharmacy. J Am Pharm Assoc. 2011;51(1):50-7.
13. DG Pittman Z Tao W Chen GD Stettin 2010 Antihypertensive medication adherence and subsequent health care utilization and cost Am J Manag Care 16 8 568 576 20712390
14. S Devine A Vlahiotis H Sundar 2010 A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy J Med Econ 13 2 203 211 20345227 10.3111/13696991003741801
15. OK Duru J Schmittdiel W Dyer M Parker C Uratsu J Chan A Karter 2010 Mail order pharmacy use and adherence to diabetes-related medications Am J Manag Care 15 1 33 40
16. OK Duru RB Gerzoff JV Selby, et al. 2009 Identifying risk factors for racial disparities in diabetes outcomes: the Translating Research into Action for Diabetes (TRIAD) Study Med Care 47 6 700 706 19480090 10.1097/MLR. 0b013e318192609d
17. WH Shrank M Stedman SL Ettner D DeLapp J Dirstine MA Brookhart MA Fischer J Avorn SM Asch 2007 Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use J Gen Intern Med 22 9 1298 1304 17647066 10.1007/s11606-007-0284-3
18. MC Sokol KA McGuigan RR Verbrugge RS Epstein 2005 Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost Medical Care 43 6 521 530 15908846 10.1097/01.mlr.0000163641.86870.af
19. PM Ho JS Rumsfeld FA Masoudi DL McClure ME Plomondon JF Steiner DJ Magid 2006 Effect of medication nonadherence on hospitalizations and mortality among patients with diabetes mellitus Arch Intern Med 166 1836 1841 17000939 10.1001/archinte.166.17.1836
20. DT Lau DP Nau 2004 Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes Diabetes Care 27 9 2149 2153 15333476 10.2337/diacare.27.9.2149 1:CAS:528:DC%2BD2cXnvFKrsb0%3D
21. JK Lee KA Grace AJ Taylor 2006 Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol. A Randomized Controlled Trial JAMA 296 2563 2571 17101639 10.1001/jama.296.21.joc60162 1:CAS:528:DC%2BD28Xht12lsbnL
22. WT Dyer RW Fairlie 2004 Do family caps reduce out of wedlock births? Evidence from Arkansas, Georgia, Indiana, New Jersey and Virginia Popul Res Policy Rev 23 441 473 10.1007/s11113-004-3462-6
23. BD Meyer 1995 Natural and quasi-experiments in economics J Bus Econ Stat 13 2 151 161 10.2307/1392369
24. E Van Gameren 2010 Health insurance and use of alternative medicine in Mexico Health Policy 98 50 57 20546965 10.1016/j.healthpol.2010.04.006
25. Newhouse JP, McClellan M. Econometrics in outcomes research: The use of instrumental variables. Annu Rev Publ Health. 1998;19:17-34.
26. S Greenland 2000 An Introduction to instrumental variables for epidemiologists Int J Epidemiol 29 722 729 10922351 10.1093/ije/29.4.722 1:STN:280:DC%2BD3cvlvVaquw%3D%3D
27. MC McClellan BJ McNeil JP Newhouse 1994 Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables JAMA 272 11 859 866 8078163 10.1001/jama.272.11.859 1:STN:280:DyaK2czlvV2rtg%3D%3D
28. SM Grundy JI Cleeman CN Merz HB Brewer Jr LT Clark DB Hunninghake RC Pasternak SC Smith Jr NJ Stone Lung National Heart Blood Institute; American College of Cardiology Foundation American Heart Association 2004 Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2 227 239 15249516 10.1161/01.CIR.0000133317.49796.0E
29. Baum CF, Shaffer ME, Stillman S. Enhanced routines for instrumental variables/generalized method of moments estimation and testing. The Stata Journal. 7(4):465-506.
30. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 26:814-23.
31. JF Steiner AV Prochazka 1997 The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 105 116 9048695 10.1016/S0895-4356(96)00268-5 1:STN:280:DyaK2s3gtVyltA%3D%3D
32. PW Choo CS Rand TS Inui, et al. 1999 Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy Med Care 37 9 846 857 10493464 10.1097/00005650-199909000-00002 1:STN:280:DyaK1MvitFajtQ%3D%3D
33. NK Choudry MA Fischer J Avorn JN Liberman S Schneeweiss J Pakes TA Brennan WH Shrank 2011 The implications of therapeutic complexity on adherence to cardiovascular medications Arch Intern Med 171 9 814 822 10.1001/ archinternmed.2010.495
34. C Richard MT Lussier 2006 Nature and frequency of exchanges on medications during primary care encounters Patient Educ Couns 64 1-3 207 216 16781108 10.1016/j.pec.2006.02.003
35. DM Tarn DA Paterniti J Heritage RD Hays RL Kravitz NS Wenger 2006 Physician communication about the cost and acquisition of newly prescribed medications Am J Manag Care 12 11 657 664 17090222
36. ME Raebel EE Lyons SE Andrade, et al. 2005 Laboratory monitoring of drugs at initiation of therapy in ambulatory care J Gen Intern Med 20 1120 1126 16423101 10.1111/j.1525-1497.2005.0257.x